23.02.2024
PRICE INQUIRY No. SEMA/32/PR48126/2024 - being conducted as a market assessment study
In connection with the implementation of the project titled “Design and development of an innovative solution – a generic drug of the GLP-1 receptor…
16.02.2024
PRICE INQUIRY no. NUSI/62/PR49446/2024 - being conducted as a market assessment study
In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
07.02.2024
PRICE INQUIRY No. SEMA/30/PR48126/2024 - being conducted as a market assessment study
In connection with the implementation of the project titled “Design and development of an innovative solution – a generic drug of the GLP-1 receptor…
02.02.2024
PRICE INQUIRY no. NUSI/61/PR43961/2024 - being conducted as a market assessment study
In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
01.02.2024
PRICE INQUIRY no. NUSI/59/PR45939/2024 - being conducted as a market assessment study
In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
23.01.2024
PRICE INQUIRY No JODO/9/PR43746/2024 - being conducted as a market assessment study
In connection with the implementation of the project entitled "Development and introduction to the market of the first non-antibiotic product for the treatment of…
Polpharma Group
We are the largest Polish manufacturer of pharmaceuticals and a leader of the…
read more